These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31071450)

  • 1. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUV
    Lin CS; Huang YY; Pan SC; Cheng CT; Liu CC; Shih CH; Ho HL; Yeh YC; Chou TY; Lee MY; Wei YH
    Mitochondrion; 2019 Jul; 47():54-63. PubMed ID: 31071450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma.
    Kuriyama K; Higuchi T; Yokobori T; Saito H; Yoshida T; Hara K; Suzuki S; Sakai M; Sohda M; Higuchi T; Tsushima Y; Asao T; Kaira K; Kuwano H; Shirabe K; Saeki H
    Cancer Sci; 2020 Jun; 111(6):1969-1978. PubMed ID: 32302443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
    Kubo Y; Tanaka K; Masuike Y; Takahashi T; Yamashita K; Makino T; Saito T; Yamamoto K; Tsujimoto T; Harino T; Kurokawa Y; Yamasaki M; Nakajima K; Eguchi H; Doki Y
    J Transl Med; 2022 Aug; 20(1):383. PubMed ID: 36038893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
    Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
    Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Ma C; Li D; Yin Y; Cao J
    Nucl Med Commun; 2015 Dec; 36(12):1181-6. PubMed ID: 26367213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
    Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
    Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
    Jun S; Park JG; Seo Y
    Cancer Imaging; 2018 Sep; 18(1):35. PubMed ID: 30257714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Yamakita I; Kurokawa T; Okada M
    Ann Thorac Surg; 2016 Oct; 102(4):1132-9. PubMed ID: 27319990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
    Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
    Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
    Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery.
    Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Ohsawa M; Hirohata R; Kitasaki N; Okada M
    Anticancer Res; 2022 Dec; 42(12):6037-6045. PubMed ID: 36456150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.
    Masuike Y; Tanaka K; Makino T; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
    PLoS One; 2018; 13(2):e0193159. PubMed ID: 29447301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines.
    Lin CS; Lee HT; Lee SY; Shen YA; Wang LS; Chen YJ; Wei YH
    Int J Mol Sci; 2012; 13(9):11228-11246. PubMed ID: 23109849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of relationship between (18)F-FDG PET/CT SUVmax of esophageal squamous cell carcinoma before treatment and postoperative survival].
    Dai L; Fu H; Wang F; Guo R; Yang YB; Lin Y; Chen KN
    Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(21):1707-1712. PubMed ID: 29925151
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hirose Y; Kaida H; Kawahara A; Matono S; Tanaka T; Kurata S; Kage M; Ishibashi M; Abe T
    Nucl Med Commun; 2016 Oct; 37(10):1053-61. PubMed ID: 27218430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
    Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
    Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
    Tanabe S; Naomoto Y; Shirakawa Y; Fujiwara Y; Sakurama K; Noma K; Takaoka M; Yamatsuji T; Hiraki T; Okumura Y; Mitani M; Kaji M; Kanazawa S; Fujiwara T
    Clin Nucl Med; 2011 Oct; 36(10):854-9. PubMed ID: 21892033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis.
    Wang J; Luo FF; Huang TJ; Mei Y; Peng LX; Qian CN; Huang BJ
    Aging (Albany NY); 2021 Sep; 13(17):21758-21777. PubMed ID: 34520390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.